Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Palantir Stock At $190

The Motley Fool on MSN · 12h
Prediction: Buying Palantir Stock Today Could Set You Up for Life
According to estimates compiled by Yahoo! Finance, sell-side analysts now expect Palantir to generate $4.2 billion in revenue this year (the 12 months ending on Dec. 31, 2025), and $5.6 billion next year. That would represent year-over-year growth of 46% and 34%, respectively.
Forbes · 2d
Palantir Stock At $190: Time To Cash Out?
The stock has climbed 2.5x since early January and now trades at around $185 per share. After such a rapid ascent, should investors holding sizable gains cash out?
TipRanks on MSN · 1d
‘Time to Wave Bye Bye,’ Says Former Bull About Palantir Stock
Palantir (NASDAQ:PLTR) stock has been the subject of a mad scramble in recent years, as investors rush to ride the big data company’s momentum.
41m

Palantir: Buy The AI Goldmine (Upgrade)

Palantir's massive government and commercial contracts, expanding AI platforms, and strong execution justify its premium ...
3don MSN

Should You Sell Palantir Stock After Its Post-Earnings Pop? The Answer May Surprise You.

The stock is up 28% in the last month. It is up close to 600% in the last year. The software provider has produced phenomenal ...
Nasdaq22d

Palantir Is Crushing the S&P This Year. Here's Why. - Nasdaq

Once again, Palantir Technologies (NASDAQ: PLTR) is easily outpacing the S&P 500 this year. As of mid-2025, the stock has more than doubled, making it the best-performing stock in the index.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy